Recombinant Human NUP62CL protein (denatured) (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human NUP62CL protein (denatured) (His tag N-Terminus) is a Human Full Length protein, in the 1 to 72 aa range, expressed in Escherichia coli, with >80%, suitable for SDS-PAGE.
View Alternative Names
NUP62L, NUP62CL, Nucleoporin-62 C-terminal-like protein
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human NUP62CL protein (denatured) (His tag N-Terminus) (AB177611)
ab177611 (3ug) on a 15% SDS-PAGE.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NUP62CL contributes to the integrity of the nuclear pore complex by participating in the assembly and disassembly of NPCs. It interacts with other nucleoporins as part of the complex structure. NUP62CL ensures effective bidirectional transport of proteins and RNA impacting cell signaling and cycle control. Its function is essential for maintaining normal cellular activities and any disruption can lead to cellular dysfunction.
Pathways
NUP62CL is a component of the nuclear transport pathway which is important for the regulation of gene expression. It interacts with other nucleoporins such as NUP98 and NUP96 facilitating the transport of transcriptional regulators and mRNA molecules. NUP62CL is also involved in the Ran GTPase cycle a pathway important for mitotic spindle assembly and subsequent cell division processes. These interactions highlight its role in cellular regulation.
Specifications
Form
Liquid
General info
Sequence similarities
Belongs to the nucleoporin NSP1/NUP62 family.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com